T1FX34 Stock Overview
Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Teleflex Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$109.30 |
| 52 Week High | US$122.56 |
| 52 Week Low | US$99.77 |
| Beta | 1.16 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -45.35% |
| 5 Year Change | n/a |
| Change since IPO | -31.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| T1FX34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 0% | 0.7% | -0.8% |
| 1Y | n/a | 15.0% | -2.9% |
Return vs Industry: Insufficient data to determine how T1FX34 performed against the BR Medical Equipment industry.
Return vs Market: Insufficient data to determine how T1FX34 performed against the BR Market.
Price Volatility
| T1FX34 volatility | |
|---|---|
| T1FX34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in BR Market | 8.2% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: T1FX34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine T1FX34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1943 | 14,500 | Liam Kelly | www.teleflex.com |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
Teleflex Incorporated Fundamentals Summary
| T1FX34 fundamental statistics | |
|---|---|
| Market cap | R$52.12b |
| Earnings (TTM) | R$1.61b |
| Revenue (TTM) | R$16.33b |
32.4x
P/E Ratio3.2x
P/S RatioIs T1FX34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| T1FX34 income statement (TTM) | |
|---|---|
| Revenue | US$3.00b |
| Cost of Revenue | US$1.33b |
| Gross Profit | US$1.67b |
| Other Expenses | US$1.38b |
| Earnings | US$296.02m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.28 |
| Gross Margin | 55.70% |
| Net Profit Margin | 9.86% |
| Debt/Equity Ratio | 39.8% |
How did T1FX34 perform over the long term?
See historical performance and comparison